Dem Staffer Who Filmed His Sexcapades in a Senate Hearing Room Later Checked...
Seinfeld Creator's Absurd Op-Ed Attacking Bill Maher Had Only One Purpose
New Jersey Republicans Are Getting Help From a Familiar Individual
Weirdo Lib Wearing What Appears to Be a Luigi Mangione T-Shirt Attacks Trump...
Former Rolling Stone Contributing Editor Does Not Hold Back in Eviscerating Taylor Lorenz
Is This Trump's Best Line From the White House Easter Egg Roll?
The Left's Obsession With Clipping Pete Hegseth Is Bordering on Psychotic
Trump Won’t Get Tricked Into Sacrificing Pete Hegseth to the Democrats
The Questions Democrats Will Not Ask
When a Wrong Narrative Hides the Truth
A Familiar Face Jumps in Race for California Governor
Trump’s DHS and DOJ Are Going After MS-13, Not Moms at School Board...
The World Needs People Day More Than Earth Day
The Savaging of the Climate Politico-Legal-Media Complex
The Moral Bankruptcy of a 'Day of Rage' and the Palestinian Legacy of...
Tipsheet

The Gambling Gamble Falls to Weather in Asia

Welcome to John Ransom’s Stocks in the News where the headlines meet the trendlines.

Stock number one: Gigamon Inc.

Gigamon slips after missed deal prompts lower Q1 outlook—Fly on the Wall

Advertisement

Shares of Gigamon (GIMO), which offers solutions to control and manage network traffic, are slipping after the company lowered its first quarter revenue outlook based on the fall-out of a large deal with an existing customer. WHAT'S NEW: Last night, Gigamon reduced its first quarter revenue view to $31M-$31.5M from its previous outlook of $34M-$35M. Prior to the company's warning, analysts consensus revenue estimate was $34.8M. The company attributed the lowered revenue to one expected large transaction from an existing customer in EMEA that did not transpire.

Symbol: GIMO

Trailing PE: NA; Forward PE: 24

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Sell Gigamon

GIMO Chart

GIMO data by YCharts

Stock number two: Mallinckrodt plc

Drug Deals Surge to New High With Mallinckrodt: Real M&A—Barron's

Mallinckrodt (MNK) Plc said yesterday that it will buy Questcor Pharmaceuticals Inc. for $5.6 billion. That propelled the amount spent on specialty drugmaker deals in the past year to almost $60 billion, the most for a 12-month period since December 2009, according to data compiled by Bloomberg. Drugmakers from Actavis Plc to Valeant Pharmaceuticals International Inc. (VRX) -- and now Mallinckrodt -- are broadening their suites of drugs through takeovers that immediately boost earnings with the help of lower corporate tax rates in countries such as Ireland.

Advertisement

Symbol: MNK

Trailing PE: 43 Forward PE: 19

PEG: 2.67

Dividend: NA

Estimate Trend: Up

Ransom Note Trendline: Hold Mallinckrodt

MNK Chart

MNK data by YCharts

Stock number three: Caesars Entertainment Corporation

Online Gambling May Not Be the Best Bet-- Motley Fool

Las Vegas Sands, MGM Resorts International, Wynn Resorts, Melco Crown Entertainment and other Macau casino companies fell hard early Monday on a report that total gambling revenue so far in April is below forecasts because of rugged weather. Caesars Entertainment (CZR), which doesn't own casinos in Asia but is the largest U.S. casino operator, was down 2%.

Symbol: CZR

Trailing PE: NA; Forward PE: NA

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Avoid Caesars Entertainment

DO Chart

DO data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement